| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 09/12/2002 | WO2002070471A1 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours |
| 09/12/2002 | WO2002070470A2 Benzophenones as inhibitors of reverse transcriptase |
| 09/12/2002 | WO2002070464A2 Hydrazones and their therapeutic use |
| 09/12/2002 | WO2002070439A2 Amination process |
| 09/12/2002 | WO2002069901A2 Cathepsin cysteine protease inhibitors |
| 09/12/2002 | WO2002044113A3 Use of(-) (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
| 09/12/2002 | WO2002017925A8 Non-symmetric tripyrrannes in the synthesis of novel macrocycles |
| 09/12/2002 | US20020128490 Amination process |
| 09/12/2002 | US20020128476 Inhibitors of cysteine protease |
| 09/12/2002 | US20020128434 Alpha-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors |
| 09/12/2002 | US20020128307 Tetramic acid-type compounds isolated from a CCR-5 active complex produced by fermentation under controlled conditions of a biologically pure culture of the microorganism, Chaetomium globosum Kunze |
| 09/12/2002 | US20020128255 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques |
| 09/12/2002 | US20020127605 Cyclophilin compound for use in the treatment of infections, nervous system, skin, ischemic and vision disorders |
| 09/12/2002 | US20020127582 Generating adenovirus-associated vector; obtain cells, transform with expression vector, propagate, recover transformed cells, propagate and recover vectors |
| 09/12/2002 | US20020124326 Contacting the substrate with a mono-, di-, or trialkoxy-substituted perfluoroalkane, perfluorocycloalkane, or perfluorocycloalkyl(ene)- containing perfluoroalkane |
| 09/12/2002 | CA2439827A1 Peptide deformylase inhibitors |
| 09/12/2002 | CA2439820A1 Benzophenones as inhibitors of reverse transcriptase |
| 09/12/2002 | CA2439644A1 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours |
| 09/12/2002 | CA2434184A1 Bisaryl derivatives having fsh receptor modulatory activity |
| 09/11/2002 | EP1238970A1 Cycloamine ccr5 receptor antagonists |
| 09/11/2002 | EP1237953A2 Polymerization of olefins |
| 09/11/2002 | EP1237869A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 09/11/2002 | EP1237866A1 Amycomycin, a process for its production and its use as a pharmaceutical |
| 09/11/2002 | EP1237865A1 A factory scale process for producing crystalline atorvastatin trihydrate hemi calcium salt |
| 09/11/2002 | EP1237864A1 Process for the preparation of amorphous atorvastatin |
| 09/11/2002 | EP1237863A1 N-substituted perfluoroalkylated pyrrolidines, process for making them and process for the addition of rf-iodide to an olefin |
| 09/11/2002 | EP1237862A1 Succinate compounds, compositions and methods of use and preparation |
| 09/11/2002 | EP1237852A1 N-phenylcarbamates having a microbicide, insecticide and acaricide effect |
| 09/11/2002 | EP1237849A1 Activators of soluble guanylate cyclase |
| 09/11/2002 | EP0900787B1 Process for preparing pyrrolidine derivatives |
| 09/11/2002 | EP0731788B1 Prolyl endopeptidase inhibitors |
| 09/11/2002 | CN1368958A Arylsulfonamido-substituted hydroxamic acid derivatives |
| 09/11/2002 | CN1368882A Neuronal death inhibitors |
| 09/11/2002 | CN1090617C Pyrole derivatives and medicinal composition |
| 09/11/2002 | CN1090614C N-(aroyl) glycine hydroxamic acid derivatives and related compounds |
| 09/10/2002 | US6448373 Inhibitors of enzymes such as phospholipase a2; treatment of inflammatory diseases including atopic dermatitis and inflammatory bowel disease |
| 09/10/2002 | US6448295 Treating cardiovascular disease; atherosclerosis, dyslipidema hypercholesterolaemia; decreasing concentrations of low density lipoprotein and raising level of high density lipoprotein |
| 09/10/2002 | US6448286 Imino pyrrolidine derivatives useful as nitric oxide synthase inhibitors |
| 09/10/2002 | US6448276 Such as 1-pyridin-3-yl-4-pyrrolidin-1-yl-but-1-ene; increasing hydration and lubrication of vaginal and cervical tissues; nicotine, epibatidine alkaloids and analogs |
| 09/10/2002 | US6448267 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 09/10/2002 | US6448250 Sulfamato hydroxamic acid metalloprotease inhibitor |
| 09/10/2002 | US6447748 Benzamide compounds for cancer imaging and therapy |
| 09/10/2002 | CA2129339C Inhibitors of thrombosis |
| 09/06/2002 | WO2002068428A1 Method of preparing cephalosporins using 4-hydroxyphenylglycine derivatives |
| 09/06/2002 | WO2002068367A1 A method to inhibit ethylene responses in plants |
| 09/06/2002 | WO2002067931A1 Treatment of tics, tremors and related disorders |
| 09/06/2002 | WO2002032868A3 2-substituted heterocyclic compounds and their use in treating multidrug resistance |
| 09/06/2002 | CA2438930A1 Treatment of tics, tremors and related disorders |
| 09/05/2002 | US20020123637 Pharmaceutically active compounds and methods of use thereof |
| 09/05/2002 | US20020123635 Polypyrrolinone based inhibitors of matrix metalloproteases |
| 09/05/2002 | US20020123634 Asymmetric derivatives of furamidines; contacting the sample DNA with above compound |
| 09/05/2002 | US20020123498 For inhibiting transport protein; therapy |
| 09/05/2002 | US20020123032 Detection of disease related genes |
| 09/05/2002 | DE10110325A1 Phenylderivate 2 Phenyl derivatives 2 |
| 09/04/2002 | EP1236716A1 Methods for making optically active 3-aminopyrrolidine-2,5-dione derivative and optically active 3-aminopyrrolidine derivative |
| 09/04/2002 | EP1235807A1 B-amino acid-, aspartic acid- and diaminopropionic-based inhibitors of factor xa |
| 09/04/2002 | EP1235800A1 Process for the preparation of amorphous atorvastatin calcium |
| 09/04/2002 | EP1235799A1 Polymorphic form of atorvastatin calcium |
| 09/04/2002 | EP1235777A2 Vitamin d analogues |
| 09/04/2002 | EP1235618A2 Bioconjugation in vivo to pulmonary or blood components |
| 09/04/2002 | EP0642506B1 Heterocyclically bisubstituted sulphonyl amino(thio)carbonyl compounds |
| 09/04/2002 | CN1367678A Method of treating hair loss using ketoamides |
| 09/04/2002 | CN1090187C HIV protease inhibitors in pharmaceutical combinations for treatment of AIDS |
| 09/04/2002 | CN1090186C HIV protease inhibitors in pharmaceutical combinations for treatment of AIDS |
| 09/03/2002 | US6444829 (2s,4r)-4-mercapto-1-(naphthalene-2-sulfonyl)-pyrrolidine-2 -carboxylic acid n'-isobutyl-n'-(4-methyl-benzenesulfonyl)-hydrazide, for example; inhibitors of metalloproteases, e.g. zinc proteases; vasodilators |
| 09/03/2002 | US6444817 Anticoagulants |
| 09/03/2002 | US6444704 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/03/2002 | US6444686 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 09/03/2002 | CA2237189C 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 09/03/2002 | CA2140626C Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 08/29/2002 | WO2002066431A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same |
| 08/29/2002 | WO2002066421A1 Rgd-analog non-peptidic molecules having anti-adhesive, anti-migration and anti-proliferative effects |
| 08/29/2002 | WO2002042273A3 Acid derivatives useful as serine protease inhibitors |
| 08/29/2002 | WO2002037937A3 Acid derivatives useful as serine protease inhibitors |
| 08/29/2002 | WO2001087288A8 Method of treating vaginal dryness with nicotinic acetylcholine receptor agonists |
| 08/29/2002 | WO2000067746A9 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 08/29/2002 | WO2000064443A9 Synergistic effects of amlodipine and atorvastatin |
| 08/29/2002 | WO1999064055A9 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors |
| 08/29/2002 | US20020120154 Method for preparing lactam |
| 08/29/2002 | US20020120140 Phosgene-free process for preparing carbamates |
| 08/29/2002 | US20020120136 Method of preparing cephalosporins using 4-hydroxyphenylglycine derivatives |
| 08/29/2002 | US20020120011 Substituted N, N-disubstituted diamino compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 08/29/2002 | US20020119994 LFA-1 Antagonist compounds |
| 08/29/2002 | US20020119992 Anticoagulants |
| 08/29/2002 | US20020119979 Cancer therapy |
| 08/29/2002 | US20020119972 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases |
| 08/29/2002 | US20020119962 Novel urea compounds, compositions and methods of use and preparation |
| 08/29/2002 | US20020119960 Drug resistance therapy |
| 08/29/2002 | US20020119956 Using thalidomine |
| 08/29/2002 | US20020119953 Sickle cell anemia |
| 08/29/2002 | US20020119932 RGD-analog non-peptidic molecules having anti-adhesive, anti-migration and anti-proliferative effects |
| 08/29/2002 | US20020119901 Coating compositions |
| 08/29/2002 | DE10106970A1 Neues Benzoylguanidinsalz New Benzoylguanidinsalz |
| 08/29/2002 | CA2432208A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same |
| 08/28/2002 | EP1233945A1 Heterocyclic ketone and thioester compounds and uses |
| 08/28/2002 | EP1140956B1 Ligands and complexes for enantioselective hydrogenation |
| 08/28/2002 | EP1124798A4 Synthesis of methylthiophenyl hydroxyketones |
| 08/28/2002 | EP1017734B1 Crosslinkable polyurea polymers |
| 08/28/2002 | EP0993445B1 New oxime sulfonates and the use thereof as latent sulfonic acids |
| 08/28/2002 | EP0885189B1 Method for the synthesis of poly-pyrrole and poly-imidazole carboxamides on a solid support |